EMEA-000347-PIP02-16-M03
Key facts
| Invented name |
Bilaxten and associated names
|
| Active substance |
Bilastine
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0526/2021
|
| PIP number |
EMEA-000347-PIP02-16-M03
|
| Pharmaceutical form(s) |
Eye drops, solution
|
| Condition(s) / indication(s) |
Treatment of allergic conjunctivitis
|
| Route(s) of administration |
Ocular use
|
| Contact for public enquiries |
FAES FARMA, S.A.
Tel. +34 944818300 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|